BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3473254)

  • 41. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies.
    Metter GE; Nathwani BN; Burke JS; Winberg CD; Mann RB; Barcos M; Kjeldsberg CR; Whitcomb CC; Dixon DO; Miller TP
    J Clin Oncol; 1985 Jan; 3(1):25-38. PubMed ID: 3965631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation.
    Percy C; O'Conor G; Ries LG; Jaffe ES
    Cancer; 1984 Oct; 54(7):1435-8. PubMed ID: 6467164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.
    Laurini JA; Perry AM; Boilesen E; Diebold J; Maclennan KA; Müller-Hermelink HK; Nathwani BN; Armitage JO; Weisenburger DD
    Blood; 2012 Dec; 120(24):4795-801. PubMed ID: 23086753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitotic counts in follicular lymphomas.
    Ellison DJ; Nathwani BN; Metter GE; Turner RR; Burke JS; Miller TP; Mann RB; Barcos M; Kjeldsberg CR; Winberg CD
    Hum Pathol; 1987 May; 18(5):502-5. PubMed ID: 3570281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of a uniform histopathologic review system of lymphoma cases. A ten-year study from the Southeastern Cancer Study Group.
    Vélez-García E; Durant J; Gams R; Bartolucci A
    Cancer; 1983 Aug; 52(4):675-9. PubMed ID: 6861104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What should be the morphologic criteria for the subdivision of follicular lymphomas?
    Nathwani BN; Metter GE; Miller TP; Burke JS; Mann RB; Barcos M; Kjeldsberg CR; Dixon DO; Winberg CD; Whitcomb CC
    Blood; 1986 Oct; 68(4):837-45. PubMed ID: 3530348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method.
    Xie S; Yu Z; Feng A; Zheng S; Li Y; Zeng Y; Lyu J
    Front Oncol; 2022; 12():942122. PubMed ID: 36237337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.
    LaCasce AS; Kho ME; Friedberg JW; Niland JC; Abel GA; Rodriguez MA; Czuczman MS; Millenson MM; Zelenetz AD; Weeks JC
    J Clin Oncol; 2008 Nov; 26(31):5107-12. PubMed ID: 18768434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glyphosate epidemiology expert panel review: a weight of evidence systematic review of the relationship between glyphosate exposure and non-Hodgkin's lymphoma or multiple myeloma.
    Acquavella J; Garabrant D; Marsh G; Sorahan T; Weed DL
    Crit Rev Toxicol; 2016 Sep; 46(sup1):28-43. PubMed ID: 27677668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The revised European-American lymphoma (REAL) classification of non-Hodgkin's lymphoma: a missed opportunity?
    Meijer CJ; van der Valk P; de Bruin PC; Willemze R
    Blood; 1995 Apr; 85(7):1971-2. PubMed ID: 7703500
    [No Abstract]   [Full Text] [Related]  

  • 51. Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory.
    Orem J; Sandin S; Weibull CE; Odida M; Wabinga H; Mbidde E; Wabwire-Mangen F; Meijer CJ; Middeldorp JM; Weiderpass E
    Clin Epidemiol; 2012; 4():339-47. PubMed ID: 23277743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Panel classification of self-reported exposure histories: a useful exposure index after a mass-casualty event.
    Van Sickle D; Wenck MA; Wenck A; Belflower A; Drociuk D; Ferdinands J
    Public Health Rep; 2007; 122(6):776-83. PubMed ID: 18051670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggressive B-cell lymphoma subtyping: a pathologists viewpoint.
    de Jong D
    Hemasphere; 2019 Jun; 3(Suppl):. PubMed ID: 35309806
    [No Abstract]   [Full Text] [Related]  

  • 54. Stanford appoints panel to review mosher case.
    Norman C
    Science; 1983 Jun; 220(4602):1133. PubMed ID: 17818477
    [No Abstract]   [Full Text] [Related]  

  • 55. Panel picks apart the studies.
    Sun M
    Science; 1984 Nov; 226(4677):951. PubMed ID: 17737340
    [No Abstract]   [Full Text] [Related]  

  • 56. [UNANIMOUS AGREEMENT IN THE FORMULATION OF DIAGNOSIS].
    DOTSOV D; MUTAFOV T
    Suvr Med (Sofiia); 1965; 16():57-9. PubMed ID: 14348729
    [No Abstract]   [Full Text] [Related]  

  • 57. The Non-Panel Movement.
    Hospital (Lond 1886); 1913 Nov; 55(1431):236-238. PubMed ID: 29840859
    [No Abstract]   [Full Text] [Related]  

  • 58. The Non-Panel Movement.
    Hospital (Lond 1886); 1913 Nov; 55(1428):152-154. PubMed ID: 29840835
    [No Abstract]   [Full Text] [Related]  

  • 59. The Non-Panel Movement.
    Hospital (Lond 1886); 1913 Nov; 55(1427):124. PubMed ID: 29840819
    [No Abstract]   [Full Text] [Related]  

  • 60. The Non-Panel Movement.
    Hospital (Lond 1886); 1913 Oct; 55(1426):100-102. PubMed ID: 29840529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.